Andreas Herrmann

Person

Pfeffingen, CH

People

Patents Grantslast 30 patents

Information Patent Grant
RANKL-specific agent for treating metastatic disease
- Patent number 12,048,744
- Issue date Jul 30, 2024
- Probiocon GmbH
- Helmut Salih
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of treating nonalcoholic steatohepatitis by administering an...
- Patent number 11,028,178
- Issue date Jun 8, 2021
- BALIOPHARMA AG
- Heike Bantel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RANKL-specific agent for treating metastatic disease
- Patent number 10,806,786
- Issue date Oct 20, 2020
- Probiocon GmbH
- Helmut Salih
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monovalent anti-huTNFR1 antibodies, encoding nucleic acids thereof...
- Patent number 10,689,452
- Issue date Jun 23, 2020
- Universitat Stuttgart
- Roland Kontermann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant bispecific antibody binding to CD20 and CD95
- Patent number 10,590,202
- Issue date Mar 17, 2020
- Baliopharm AG
- Andreas Herrmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-huTNFR1 antibody and methods of use thereof for treatment
- Patent number 8,859,739
- Issue date Oct 14, 2014
- Baliopharm AG
- Roland Kontermann
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE
- Publication number 20210128722
- Publication date May 6, 2021
- Probiocon GmbH
- Helmut SALIH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-huTNFR1 THERAPY OF NONALCOHOLIC STEATOHEPATITIS
- Publication number 20200299396
- Publication date Sep 24, 2020
- BALIOPHARM AG
- Heike BANTEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CANCER COMBINATION TREATMENT
- Publication number 20190218302
- Publication date Jul 18, 2019
- Probiocon GmbH
- Andreas HERRMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOVALENT INHIBITOR OF huTNFR1 INTERACTION
- Publication number 20190144555
- Publication date May 16, 2019
- UNIVERSITAT STUTTGART
- Roland KONTERMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE
- Publication number 20170319687
- Publication date Nov 9, 2017
- Probiocon GmbH
- Helmut SALIH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT BISPECIFIC ANTIBODY BINDING TO CD20 AND CD95
- Publication number 20150274833
- Publication date Oct 1, 2015
- BALIOPHARM AG
- Andreas Herrmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-huTNFR1 ANTIBODY
- Publication number 20130251707
- Publication date Sep 26, 2013
- BALIOPHARM AG
- Roland Kontermann
- C07 - ORGANIC CHEMISTRY

Andreas Herrmann

Person

Patents Grantslast 30 patents

RANKL-specific agent for treating metastatic disease

Method of treating nonalcoholic steatohepatitis by administering an...

RANKL-specific agent for treating metastatic disease

Monovalent anti-huTNFR1 antibodies, encoding nucleic acids thereof...

Recombinant bispecific antibody binding to CD20 and CD95

Anti-huTNFR1 antibody and methods of use thereof for treatment

Patents Applicationslast 30 patents

RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE

ANTI-huTNFR1 THERAPY OF NONALCOHOLIC STEATOHEPATITIS

ANTI-CANCER COMBINATION TREATMENT

MONOVALENT INHIBITOR OF huTNFR1 INTERACTION

RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE

RECOMBINANT BISPECIFIC ANTIBODY BINDING TO CD20 AND CD95

ANTI-huTNFR1 ANTIBODY